Sunday, September 12, 2010

ECMO getting momentum!

Early ECMO-assisted primary PCI improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock

Objectives: This study tested the hypothesis that early extracorporeal membrane oxygenator offered additional benefits in improving 30-day outcomes in patients with acute ST-segment elevation myocardial infarction complicated with profound cardiogenic shock undergoing primary percutaneous coronary intervention.

Methods: Between May 1993 and July 2002, 920 patients with acute ST-segment elevation myocardial infarction underwent primary percutaneous coronary intervention. Of these patients, 12.5% (115) with cardiogenic shock were enrolled in this study (group 1). Between August 2002 and December 2009, 1650 patients with acute ST-segment elevation myocardial infarction underwent primary percutaneous coronary intervention. Of these patients, 13.3% (219) complicated with cardiogenic shock were enrolled (group 2).

Results:

  • The incidence of profound shock (defined as systolic blood pressure remaining less than/=75 mm Hg after intra-aortic balloon pump and inotropic agent supports) was similar in both groups

Extracorporeal membrane oxygenator support, which was available only for patients in group 2, was performed in the catheterization room.

  • The results demonstrated that final thrombolysis in myocardial infarction grade 3 flow in infarct-related artery was similar between the two groups
  • Total 30-day mortality and the mortality of patients with profound shock were lower in group 2 than in group 1
  • The hospital survival time was remarkably longer in patients in group 2 than in patients in group 1

Conclusion: Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day outcomes in patients with ST-segment elevation myocardial infarction with complicated with profound cardiogenic shock.


Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock - Critical Care Medicine. 38(9):1810-1817, September 2010.